Tag: VTE
Innova Vascular announces successful early commercial use of Laguna thrombectomy system...
Innova Vascular has announced successful early commercial use of the company's Laguna thrombectomy system. Physicians at UCLA Medical Center in Los Angeles, USA, and...
The pulmonary arterial tree—it is time we branch out
Nicolas J Mouawad (McLaren Health System, Bay City, USA) urges vascular surgeons to “get out of their comfort zone” and become more involved in...
New study demonstrates IVC filters “safe and effective” in treating venous...
Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into...
Arteriovenous graft use linked to venous thromboembolism risk in haemodialysis patients
In an observational cohort study of Medicare beneficiaries receiving haemodialysis, the use of an arteriovenous graft (AVG) compared with an arteriovenous fistula (AVF) was...
Michael Cerminaro to succeed Marvin Woodall as CEO of Thrombolex
Thrombolex has announced that its board of directors has named Michael Cerminaro chief executive officer (CEO) effective 13 July 2022, the date of the...
Cordis makes strategic investment in E2, a developer of next-generation thrombectomy...
Cordis has announced a strategic investment venture that will expand the scope of the global cardiovascular technology company into the venous thromboembolism (VTE) market...
Prolonged TV watching may increase risk of venous thromboembolism
A new study reports that watching TV for four hours a day or more is associated with a 35% higher risk of venous thromboembolism...
FDA approval granted to calf stimulation device for patients at high...
UK-based Sky Medical Technology has received US Food and Drug Administration (FDA) 510(k) clearance for its "geko" device for stimulation of the calf muscles...
